Skip to main content

Exercise-induced Joint Pain

0
Pipeline Programs
1
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Biocorp
BiocorpFrance - Issoire
3 programs
Move3™N/A1 trial
NEM® + BIOCURC®N/A1 trial
NEM® brand eggshell membraneN/A1 trial
Active Trials
NCT04215198Completed85Est. Jan 2019
NCT03769857Completed84Est. Apr 2019
NCT03679923Completed84Est. Nov 2018

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
BiocorpNEM® + BIOCURC®
BiocorpMove3™
BiocorpNEM® brand eggshell membrane

Clinical Trials (3)

Total enrollment: 253 patients across 3 trials

NCT03769857BiocorpNEM® + BIOCURC®

NEM® + BIOCURC® Versus Placebo in Exercised-induced Joint Pain, Stiffness, & Cartilage Turnover in Healthy Men & Women

Start: Jan 2019Est. completion: Apr 201984 patients
N/ACompleted
NCT04215198BiocorpMove3™

NEM® + KD PUR® Fish Oil Versus Placebo in Exercised-induced Joint Pain, Stiffness, & Cartilage Turnover in Healthy Men & Women

Start: Sep 2018Est. completion: Jan 201985 patients
N/ACompleted
NCT03679923BiocorpNEM® brand eggshell membrane

NEM® Versus Placebo in Exercised-induced Joint Pain, Stiffness, & Cartilage Turnover in Healthy Men & Women

Start: Sep 2018Est. completion: Nov 201884 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.